{"timestamp": 1771603402.992941, "value": {"ticker": "GOSS", "company_name": "Gossamer Bio, Inc.", "short_name": "Gossamer Bio, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 512675552, "float_shares": 191048615, "shares_outstanding": 231456247, "short_ratio": 5.77, "short_percent_of_float": 0.123, "shares_short": 26779236, "shares_short_prior": 24114833, "insider_percent_held": 0.0416, "institution_percent_held": 0.80261004, "total_cash": 180224000, "total_debt": 202876000, "total_revenue": 44051000, "revenue_growth": 0.402, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 1.0, "operating_margins": -3.13209, "debt_to_equity": 0, "current_ratio": 3.284, "book_value": -0.356, "price_to_book": -6.22191, "operating_cashflow": -158432992, "free_cashflow": -82003128, "price": 2.215, "52w_high": 3.87, "52w_low": 0.76, "avg_volume": 4544553, "avg_volume_10d": 6190500, "full_time_employees": 144, "audit_risk": 6, "overall_risk": 8}}